A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)

Clinical trial NCT05859217 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05859217
Sponsor: Jun Zhang, MD, PhD
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer NSCLC Stage IV Metastatic NSCLC - Non-Small Cell Lung Cancer Advanced NSCLC

Start date: 2024-12-01
Primary completion: 2026-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.